cifenline has been researched along with Atrial Fibrillation in 50 studies
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It has been reported that bepridil is as good as amiodarone in converting persistent atrial fibrillation (AF) to sinus rhythm (SR)." | 9.13 | Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm. ( Aoyama, H; Enomoto, M; Hirayama, A; Imai, S; Kushiro, T; Saito, F; Takase, H; Yagi, H; Yamaji, S; Yokoyama, K, 2008) |
| "The objective of this study was to compare the efficacy and safety of cibenzoline (130 mg twice a day) and sustained-release hydroquinidine (300 mg twice a day) in the prevention of recurrent atrial fibrillation (AF)." | 9.08 | [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study]. ( Brembilla-Perrot, B; Gabriel, A; Lardoux, H; Levy, S; Marchand, X; Scheck, F; Touboul, P, 1995) |
| "This multicentre, randomized, double-blind study, conducted in parallel groups, was designed to compare the efficacy and safety of cibenzoline (C) and oral propafenone (P) in the prevention of recurrent atrial arrhythmias (M) over a 6-month period." | 9.08 | [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. ( Bleinc, D; Canler, A; Lardoux, H; Maison Blanche, P; Marchand, X; Péraudeau, P; Rouesnel, P; Scheck, F, 1996) |
| "The efficacy of oral cibenzoline (260 mg/day and 320 mg/day) and flecainide (200 mg/day and 300 mg/day) in the conversion of chronic atrial fibrillation to sinus rhythm were compared in 31 patients in a randomized order." | 9.07 | Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation. ( Kühlkamp, V; Risler, T; Schmid, F; Seipel, L, 1991) |
| "This case report describes agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a 70-year-old woman with paroxysmal atrial fibrillation (AF)." | 7.78 | Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation. ( Hayashi, H; Horie, M; Kitoh, K; Mitsunami, K, 2012) |
| "The relationship between the efficacy of the anticholinergic action of disopyramide, cibenzoline and aprindine and age was examined in patients with paroxysmal and persistent atrial fibrillation." | 7.72 | [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients]. ( Abe, N; Horiuchi, D; Kameda, K; Komatsu, T; Nakamura, S; Oikawa, K; Okumura, K; Owada, S; Suzuki, O; Tomita, H; Yomogida, K, 2003) |
| "The probability of absence of recurrence at 6 months was 36 +/- 11% in Group C and 55 +/- 10% in Group D (p = NS)." | 6.69 | [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia]. ( Baudouy, Y; Bine-Scheck, F; Cheikel, J; Dambrine, P; Flammang, D; Graux, P; Jouannon, C; Leenhardt, A; Piot, O, 1998) |
| "It has been reported that bepridil is as good as amiodarone in converting persistent atrial fibrillation (AF) to sinus rhythm (SR)." | 5.13 | Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm. ( Aoyama, H; Enomoto, M; Hirayama, A; Imai, S; Kushiro, T; Saito, F; Takase, H; Yagi, H; Yamaji, S; Yokoyama, K, 2008) |
| "The objective of this study was to compare the efficacy and safety of cibenzoline (130 mg twice a day) and sustained-release hydroquinidine (300 mg twice a day) in the prevention of recurrent atrial fibrillation (AF)." | 5.08 | [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study]. ( Brembilla-Perrot, B; Gabriel, A; Lardoux, H; Levy, S; Marchand, X; Scheck, F; Touboul, P, 1995) |
| "This multicentre, randomized, double-blind study, conducted in parallel groups, was designed to compare the efficacy and safety of cibenzoline (C) and oral propafenone (P) in the prevention of recurrent atrial arrhythmias (M) over a 6-month period." | 5.08 | [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study]. ( Bleinc, D; Canler, A; Lardoux, H; Maison Blanche, P; Marchand, X; Péraudeau, P; Rouesnel, P; Scheck, F, 1996) |
| "The efficacy of oral cibenzoline (260 mg/day and 320 mg/day) and flecainide (200 mg/day and 300 mg/day) in the conversion of chronic atrial fibrillation to sinus rhythm were compared in 31 patients in a randomized order." | 5.07 | Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation. ( Kühlkamp, V; Risler, T; Schmid, F; Seipel, L, 1991) |
| " These antiarrhythmics, prescribed to prevent atrial fibrillation (3 patients) and atrial flutter (5 patients), were flecainide in 4 cases, propafenone in 2 cases and cibenzoline and hydroquinidine respectively associated with digitoxine and propranolol." | 4.79 | [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications]. ( Aouate, P; Benassar, A; Fontaine, G; Frank, R; Jacquemin, M; Laborde, JP; Tageddine, R; Tonet, J; Turlure, A, 1995) |
| "This case report describes agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a 70-year-old woman with paroxysmal atrial fibrillation (AF)." | 3.78 | Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation. ( Hayashi, H; Horie, M; Kitoh, K; Mitsunami, K, 2012) |
| "The relationship between the efficacy of the anticholinergic action of disopyramide, cibenzoline and aprindine and age was examined in patients with paroxysmal and persistent atrial fibrillation." | 3.72 | [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients]. ( Abe, N; Horiuchi, D; Kameda, K; Komatsu, T; Nakamura, S; Oikawa, K; Okumura, K; Owada, S; Suzuki, O; Tomita, H; Yomogida, K, 2003) |
| " The patient had had paroxysmal atrial fibrillation for one year and had been treated with digoxin and cibenzoline succinate." | 3.70 | [Sudden cardiac arrest after induction of general anesthesia: a case report]. ( Kabutan, K; Mishima, M; Morimoto, N; Takehisa, S; Taniguchi, M, 2000) |
| "Termination and long-term prevention of paroxysmal atrial fibrillation by cibenzoline has a high degree of efficacy in patients with both day and night onset of paroxysmal atrial fibrillation." | 2.70 | [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset]. ( Kimura, M; Kobayashi, T; Komatsu, T; Nakamura, S; Okumura, K; Owada, S; Saito, E, 2001) |
| "The probability of absence of recurrence at 6 months was 36 +/- 11% in Group C and 55 +/- 10% in Group D (p = NS)." | 2.69 | [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia]. ( Baudouy, Y; Bine-Scheck, F; Cheikel, J; Dambrine, P; Flammang, D; Graux, P; Jouannon, C; Leenhardt, A; Piot, O, 1998) |
| "Seventeen patients had documented recurrence of atrial arrhythmia (9 in the cibenzoline group, 8 in the flecainide group) during the study." | 2.68 | Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study. ( Babuty, D; D'Hautefeuille, B; Mycinsky, C; Peraudeau, P; Pruvost, P; Scheck, F, 1995) |
| "The presenting arrhythmia was atrial fibrillation in 15 patients, atrial flutter in 5, ectopic atrial tachycardia in 11, and paroxysmal atrioventricular (AV) junctional reentrant tachycardia in 6 patients." | 2.68 | Intravenous cibenzoline in the management of acute supraventricular tachyarrhythmias. ( Bru, P; Cointe, R; Lévy, S; Paganelli, F; Ricard, P, 1995) |
| "In the not-responders, the mean time to recurrence was 75 +/- 48 days in group C and 75 +/- 62 days in group F(NS)." | 2.68 | [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias]. ( Babuty, D; Brembilla-Perrot, B; Breuillac, JC; Fauchier, JP; Funck, F; Garnier, LF; Maison-Blanche, P; Medvedowsky, JL; Peraudeau, P; Rouesnel, P; Scheck, F, 1997) |
| "A 54-year-old woman had been treated for hypertrophic cardiomyopathy and paroxysmal atrial fibrillation since 1992." | 1.30 | Hypertrophic cardiomyopathy with mid-ventricular obstruction and splenic infarction associated with paroxysmal atrial fibrillation: a case report. ( Hamada, M; Hara, Y; Hashida, H; Hiasa, G; Hiwada, K; Ikeda, S; Kitami, Y; Matsumoto, Y; Ohtsuka, T; Shigematsu, Y; Tokuyasu, K, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.00) | 18.7374 |
| 1990's | 22 (44.00) | 18.2507 |
| 2000's | 24 (48.00) | 29.6817 |
| 2010's | 2 (4.00) | 24.3611 |
| 2020's | 1 (2.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okishige, K | 1 |
| Shigeta, T | 1 |
| Nishimura, T | 1 |
| Nakamura, RA | 1 |
| Hirao, T | 1 |
| Yoshida, H | 1 |
| Yamauchi, Y | 1 |
| Keida, T | 1 |
| Sasano, T | 1 |
| Hirao, K | 2 |
| Valderrábano, M | 1 |
| Komatsu, T | 6 |
| Tachibana, H | 3 |
| Sato, Y | 2 |
| Ozawa, M | 2 |
| Ohshima, K | 1 |
| Orii, M | 1 |
| Kunigida, F | 1 |
| Nakamura, M | 3 |
| Miyakoshi, M | 1 |
| Ikeda, T | 1 |
| Miwa, Y | 1 |
| Sakaki, K | 1 |
| Ishiguro, H | 1 |
| Abe, A | 1 |
| Tsukada, T | 1 |
| Mera, H | 1 |
| Yusu, S | 1 |
| Yoshino, H | 1 |
| Satoh, Y | 1 |
| Kunugita, F | 1 |
| Tashiro, A | 1 |
| Okabayashi, H | 1 |
| Hayashi, H | 1 |
| Kitoh, K | 1 |
| Mitsunami, K | 1 |
| Horie, M | 1 |
| Shirayama, T | 1 |
| Shiraishi, H | 1 |
| Yoshida, S | 1 |
| Matoba, Y | 1 |
| Imai, H | 1 |
| Nakagawa, M | 2 |
| Niakara, A | 1 |
| Nébié, LV | 1 |
| Samadoulougou, AK | 1 |
| Kaboré, NJ | 1 |
| Ouandaogo, BJ | 1 |
| Drabo, YJ | 1 |
| Nakamura, S | 3 |
| Suzuki, O | 1 |
| Yomogida, K | 2 |
| Horiuchi, D | 2 |
| Abe, N | 1 |
| Kameda, K | 2 |
| Owada, S | 3 |
| Tomita, H | 2 |
| Oikawa, K | 2 |
| Okumura, K | 4 |
| Fujiki, A | 1 |
| Sakabe, M | 1 |
| Nishida, K | 1 |
| Mizumaki, K | 1 |
| Inoue, H | 1 |
| Kakugawa, H | 1 |
| Shimizu, A | 1 |
| Yamagata, T | 1 |
| Esato, M | 1 |
| Ueyama, T | 1 |
| Yoshiga, Y | 1 |
| Kanemoto, M | 1 |
| Matsuzaki, M | 1 |
| Shan, Z | 1 |
| Van Der Voort, PH | 1 |
| Blaauw, Y | 2 |
| Duytschaever, M | 2 |
| Allessie, MA | 6 |
| Majima, T | 1 |
| Takagi, C | 1 |
| Koike, Y | 1 |
| Shigemoto, M | 1 |
| Yamada, T | 1 |
| Akagi, T | 1 |
| Kuriu, K | 1 |
| Tanaka, H | 1 |
| Makita, S | 1 |
| Ito, F | 1 |
| Mizuno, T | 1 |
| Tabuchi, N | 1 |
| Arai, H | 1 |
| Sunamori, M | 1 |
| Yamashita, T | 1 |
| Sekiguchi, A | 1 |
| Iwasaki, YK | 1 |
| Sagara, K | 1 |
| Hatano, S | 1 |
| Iinuma, H | 1 |
| Aizawa, T | 1 |
| Fu, LT | 1 |
| Nakamura, A | 1 |
| Itoh, S | 1 |
| Gotoh, A | 1 |
| Hoshi, N | 1 |
| Eijsbouts, S | 1 |
| Ausma, J | 1 |
| Schotten, U | 1 |
| Anderson, ME | 1 |
| Hasegawa, M | 1 |
| Nasuhara, Y | 1 |
| Maki, N | 1 |
| Miura, T | 1 |
| Betsuyaku, T | 1 |
| Hizawa, N | 1 |
| Nishimura, M | 1 |
| Onozuka, H | 1 |
| Tsutsui, H | 1 |
| Meeus, R | 1 |
| Verpooten, GA | 1 |
| De Paep, R | 1 |
| Paelinck, BP | 1 |
| Neels, H | 1 |
| Cooreman, S | 1 |
| De Doncker, M | 1 |
| Jorens, PG | 1 |
| Imai, S | 1 |
| Saito, F | 1 |
| Takase, H | 1 |
| Enomoto, M | 1 |
| Aoyama, H | 1 |
| Yamaji, S | 1 |
| Yokoyama, K | 1 |
| Yagi, H | 1 |
| Kushiro, T | 1 |
| Hirayama, A | 1 |
| Babuty, D | 2 |
| D'Hautefeuille, B | 1 |
| Scheck, F | 5 |
| Mycinsky, C | 1 |
| Pruvost, P | 1 |
| Peraudeau, P | 3 |
| Hermida, JS | 1 |
| Mabo, P | 1 |
| Rouesnel, P | 4 |
| Canler, A | 3 |
| Barthélémy, M | 1 |
| Wanszelbaum, H | 1 |
| Bru, P | 1 |
| Cointe, R | 1 |
| Paganelli, F | 1 |
| Ricard, P | 1 |
| Lévy, S | 2 |
| Pisapia, A | 1 |
| Bine-Scheck, F | 3 |
| Schenowitz, A | 2 |
| Domerego, JJ | 2 |
| Maraud, L | 1 |
| Labban, N | 1 |
| Viart, R | 1 |
| Aubry, P | 1 |
| Beruben, E | 1 |
| Medvedowsky, JL | 3 |
| Dambrine, P | 2 |
| Garnier, LF | 2 |
| Labaki, F | 1 |
| Piechaczyk, P | 1 |
| Manz, M | 1 |
| Lüderitz, B | 1 |
| Brugada, J | 1 |
| Gürsoy, S | 1 |
| Brugada, P | 1 |
| Atié, J | 1 |
| Guiraudon, G | 1 |
| Andries, E | 1 |
| Andrivet, P | 1 |
| Mach, V | 1 |
| Gnoc, CV | 1 |
| Aouate, P | 1 |
| Frank, R | 1 |
| Fontaine, G | 1 |
| Tonet, J | 1 |
| Tageddine, R | 1 |
| Benassar, A | 1 |
| Turlure, A | 1 |
| Jacquemin, M | 1 |
| Laborde, JP | 1 |
| Touboul, P | 1 |
| Brembilla-Perrot, B | 2 |
| Gabriel, A | 1 |
| Lardoux, H | 2 |
| Marchand, X | 2 |
| Kasuga, A | 1 |
| Maruyama, H | 1 |
| Sato, T | 1 |
| Nogawa, S | 1 |
| Mitamura, H | 1 |
| Saruta, T | 1 |
| Maison Blanche, P | 1 |
| Bleinc, D | 1 |
| Maison-Blanche, P | 1 |
| Fauchier, JP | 1 |
| Breuillac, JC | 1 |
| Funck, F | 1 |
| Piot, O | 1 |
| Flammang, D | 1 |
| Cheikel, J | 1 |
| Jouannon, C | 1 |
| Graux, P | 1 |
| Baudouy, Y | 1 |
| Leenhardt, A | 1 |
| Wijffels, MC | 2 |
| Dorland, R | 2 |
| Tokuyasu, K | 1 |
| Hara, Y | 1 |
| Matsumoto, Y | 1 |
| Hashida, H | 1 |
| Ikeda, S | 1 |
| Ohtsuka, T | 1 |
| Hiasa, G | 1 |
| Kitami, Y | 1 |
| Shigematsu, Y | 1 |
| Hamada, M | 1 |
| Hiwada, K | 1 |
| Honda, T | 2 |
| Soejima, H | 1 |
| Kabutan, K | 1 |
| Mishima, M | 1 |
| Takehisa, S | 1 |
| Morimoto, N | 1 |
| Taniguchi, M | 1 |
| Mast, F | 1 |
| Hoekstra, BP | 2 |
| Diks, CG | 2 |
| DeGoede, J | 2 |
| Kimura, M | 2 |
| Saito, E | 1 |
| Kobayashi, T | 1 |
| Inoue, D | 1 |
| Ishibashi, K | 1 |
| Sakai, R | 1 |
| Inoue, M | 1 |
| Omori, I | 1 |
| Asayama, J | 1 |
| Kühlkamp, V | 4 |
| Schmid, F | 2 |
| Risler, T | 2 |
| Seipel, L | 4 |
| Ickrath, O | 2 |
| Meerhof, J | 1 |
| Schmidt, F | 1 |
| Mayer, F | 2 |
| Haasis, R | 1 |
| Ress, KM | 1 |
| Krämer, BK | 1 |
| Liebich, HM | 1 |
| Frances, Y | 1 |
| Luccioni, R | 1 |
| Delaage, M | 1 |
| Donnarel, G | 1 |
| Quiret, JC | 1 |
3 reviews available for cifenline and Atrial Fibrillation
| Article | Year |
|---|---|
[Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Imidazoles; Inject | 1995 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Fle | 1993 |
[Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Th | 1995 |
18 trials available for cifenline and Atrial Fibrillation
| Article | Year |
|---|---|
A randomized study on the efficacy of intravenous cibenzoline and pilsicainide administered prior to electrical cardioversion in patients with lone paroxysmal and persistent atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Natriuretic Factor; Electric Countershock; | 2009 |
Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Surgi | 2010 |
Role of fibrillation cycle length in spontaneous and drug-induced termination of human atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Humans; Imidazoles; Middle Aged; P | 2003 |
Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy.
Topics: Adult; Age Factors; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Over Studies; Disease-F | 2006 |
Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Natriuretic Factor; Bepridil; Drug | 2008 |
Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Drug Toleran | 1995 |
[Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Imidazoles; Inject | 1995 |
Intravenous cibenzoline in the management of acute supraventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fib | 1995 |
[Value of cibenzoline in the preventive treatment of recurrent atrial arrhythmia].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atr | 1994 |
[Study of the efficacy and tolerability of oral administration of cibenzoline in the prevention of recurrence of symptomatic atrial fibrillation].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Electroc | 1994 |
[Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Delayed-Action Preparations; Double-Blind | 1995 |
[Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation | 1996 |
[Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Flecainide; Humans | 1997 |
[A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Double-Blind Method; Female; Humans | 1998 |
Long-term low-dose cibenzoline in patients with chronic renal failure undergoing hemodialysis.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Respon | 2000 |
[Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Follow-Up Studies; | 2001 |
Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Female; Flecainid | 1991 |
[Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; | 1985 |
30 other studies available for cifenline and Atrial Fibrillation
| Article | Year |
|---|---|
Chemical mapping as a predictor of vein of Marshall ethanol ablative effects.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Contrast Media; Coronary Angio | 2020 |
Quantitative assessment of cibenzoline administration for vagally mediated paroxysmal atrial fibrillation using frequency-domain heart rate variability analysis.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cholinergic Antagonists; Disopyramide; Electrocardiogra | 2009 |
Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation.
Topics: Administration, Oral; Aged; Agranulocytosis; Anti-Arrhythmia Agents; Antithrombins; Atrial Fibrillat | 2012 |
Atrial fibrillation threshold predicted long-term efficacy of pharmacological treatment of patients without structural heart disease.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Disopyramide; Electrophysiologic Techn | 2002 |
[Efficacy of cibenzoline in a case of atrial fibrillation due to cardiac thyrotoxicosis].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Imidazoles; | 1999 |
[Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Autonomic Nervous System; Circadian Rh | 2003 |
Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electrophysiology; Female; H | 2003 |
Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potential Mapping; Goats; Heart A | 2004 |
[Cibenzoline-succinate-induced hypoglycemia].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Hypoglycemia; Imidazoles | 2004 |
Oral cibenzoline reduces postoperative atrial fibrillation in coronary artery bypass grafting.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Cor | 2005 |
Cibenzoline attenuates upregulation of Kv1.5 channel gene expression by experimental paroxysmal atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrophysiology; Heart Atria; Heart Conducti | 2005 |
[Coronary vasospasm induced by cibenzoline succinate in a patient with brugada-type electrocardiogram].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Vasospasm; Electrocardiography; Humans; | 2005 |
Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, | 2006 |
Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Heart Conductio | 2006 |
[Cibenzoline succinate induced pneumonitis].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Imidazoles; Male; Pneumonia | 2006 |
Cibenzoline intoxication: effect of combined hemoperfusion-hemodialysis on plasma clearance.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Overdose; Female; Half-Life; Hemoperfusion; | 2008 |
Cibenzoline transforms random re-entry into ordered re-entry in the atria.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Depression, Chemical; Ele | 1993 |
A clinical study of intravenous cibenzoline in selected patients with recent-onset atrial tachyarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Humans; Imidazoles; | 1993 |
Myasthenia-like syndrome induced by overdosage of cibenzoline.
Topics: Aged; Anti-Arrhythmia Agents; Aortic Aneurysm; Aortic Dissection; Atrial Fibrillation; Blepharoptosi | 1996 |
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Disease Models, Animal; Elect | 1999 |
Hypertrophic cardiomyopathy with mid-ventricular obstruction and splenic infarction associated with paroxysmal atrial fibrillation: a case report.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Echocardiography; Female; | 1999 |
[Sudden cardiac arrest after induction of general anesthesia: a case report].
Topics: Aged; Anesthesia, General; Anesthetics, Inhalation; Anti-Arrhythmia Agents; Atrial Fibrillation; Bre | 2000 |
Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female | 2000 |
Spatial correlation analysis of atrial activation patterns during sustained atrial fibrillation in conscious goats.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Consciousness; Goats; Heart Atria; Heart Condu | 2000 |
Spatial correlation analysis of the pharmacological conversion of sustained atrial fibrillation in conscious goats by cibenzoline.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Consciousness; Goats; Heart Atria; Heart Condu | 2000 |
[Relationship between long-term preventive efficacy of cibenzoline and atrial natriuretic peptide in patients with paroxysmal atrial fibrillation].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Natriuretic Factor; Female; Humans; Imidaz | 2002 |
[Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Differential Thresho | 1992 |
[Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Catheterization; Cardiac Pacing, A | 1990 |
Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular | 1990 |
Quantification of cibenzoline and its imidazole metabolite by high-performance liquid chromatography in human serum.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Chromatography, High Pressure Liquid; Humans; Imidazole | 1990 |